Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Opioid crisis

- PMLiVE

US Supreme Court halts Purdue Pharma $6bn bankruptcy settlement

The company has been blamed for fuelling the opioid crisis by promoting its drug OxyContin

- PMLiVE

US Supreme Court asked to block Purdue Pharma bankruptcy settlement

The company has been blamed for fuelling the opioid crisis with the promotion of its drug OxyContin

- PMLiVE

FDA external report recommends actions to address US opioid crisis

Over 100,000 Americans died from a drug overdose in 2021, with 70,000 of those due to opioids

- PMLiVE

Teva reaches proposed $4.25bn agreement to settle US opioid lawsuits

The figure includes the supply of up to $1.2bn of Teva’s Narcan, a life-saving medication which can reverse an overdose from opioids

- PMLiVE

US bankruptcy judge approves Purdue Pharma’s $6bn opioid settlement plan

The Sackler family will pay the amount over 18 years to victims of addiction and US states

- PMLiVE

J&J, distributors reach $26bn settlement to address the opioid crisis in the US

The proposed agreement would resolve claims of both states and local governments in the US

- PMLiVE

Merck’s appeal to restore hepatitis C patent verdict against Gilead fails

US Supreme Court rejects Merck’s appeal over patent dispute verdict of $2.54bn

- PMLiVE

Purdue to pay over $8bn to settle opioid-related criminal claims

Claims relate to Purdue's involvement in fuelling the opioid addiction crisis

- PMLiVE

US states claim Purdue Pharma owes $2.2 trillion over opioid crisis

Company faces new accusations of dishonest marketing tactics

- PMLiVE

Mallinckrodt reaches tentative $1.6bn opioid settlement

Agreement reached with a plaintiff's executive committee

- PMLiVE

US states reject drug distributors’ opioid settlement

The Wall Street Journal reports at least 21 states want a larger settlement

- PMLiVE

J&J proposes $4bn in cash to settle opioid crisis allegations

Upcoming federal trial puts a number of companies in the spotlight

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links